1. Home
  2. HGBL vs IVVD Comparison

HGBL vs IVVD Comparison

Compare HGBL & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HGBL
  • IVVD
  • Stock Information
  • Founded
  • HGBL 1937
  • IVVD 2020
  • Country
  • HGBL United States
  • IVVD United States
  • Employees
  • HGBL N/A
  • IVVD N/A
  • Industry
  • HGBL Business Services
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • HGBL Consumer Discretionary
  • IVVD Health Care
  • Exchange
  • HGBL Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • HGBL 75.5M
  • IVVD 69.0M
  • IPO Year
  • HGBL N/A
  • IVVD 2021
  • Fundamental
  • Price
  • HGBL $2.11
  • IVVD $0.93
  • Analyst Decision
  • HGBL Strong Buy
  • IVVD Strong Buy
  • Analyst Count
  • HGBL 1
  • IVVD 3
  • Target Price
  • HGBL $4.00
  • IVVD $5.85
  • AVG Volume (30 Days)
  • HGBL 66.8K
  • IVVD 3.1M
  • Earning Date
  • HGBL 05-08-2025
  • IVVD 05-15-2025
  • Dividend Yield
  • HGBL N/A
  • IVVD N/A
  • EPS Growth
  • HGBL N/A
  • IVVD N/A
  • EPS
  • HGBL 0.12
  • IVVD N/A
  • Revenue
  • HGBL $46,659,000.00
  • IVVD $36,688,000.00
  • Revenue This Year
  • HGBL $11.74
  • IVVD $606.63
  • Revenue Next Year
  • HGBL $8.09
  • IVVD $83.30
  • P/E Ratio
  • HGBL $18.19
  • IVVD N/A
  • Revenue Growth
  • HGBL N/A
  • IVVD N/A
  • 52 Week Low
  • HGBL $1.52
  • IVVD $0.35
  • 52 Week High
  • HGBL $2.74
  • IVVD $2.74
  • Technical
  • Relative Strength Index (RSI)
  • HGBL 49.88
  • IVVD 63.94
  • Support Level
  • HGBL $2.01
  • IVVD $0.81
  • Resistance Level
  • HGBL $2.18
  • IVVD $1.00
  • Average True Range (ATR)
  • HGBL 0.09
  • IVVD 0.12
  • MACD
  • HGBL -0.00
  • IVVD 0.02
  • Stochastic Oscillator
  • HGBL 38.46
  • IVVD 64.76

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: